In a recent study, researchers demonstrated that conditional small RNA molecules can effectively kill lab-grown human brain, prostate and bone cancer cells in a mutation-specific manner. The treatment separates the "diagnosis" and "treatment" aspects of chemotherapy, so a cell is killed if -- and only if -- it is diagnosed with a mutation.